Resistance training is accompanied by cardiac hypertrophy but the role of ReninAngiotensin-System (RAS) in this response is elusive. We evaluated this question in 36 male Wistar rats divided in 6 groups: Control (n=6); Trained (n=6); Control + Losartan (10mg.kg 
INTRODUCTION
Cardiac hypertrophy is the adaptation of the heart to altered mechanical or hormonal stimuli. Exercise training, such as resistance training (RT), is a known hypertrophic stimulus for cardiac enlargement due to pressure-overload imposed to the heart during the training when the blood pressure may reach peaks of 480/350 mmHg (19, 21) . Many studies have demonstrated that hemodynamic overload activates renin-angiotensin system (RAS) in the heart (8, 15).
The RAS is a cascade of enzymatic action that plays an important role in cardiovascular homoeostasis by influencing vascular tone, fluid and electrolyte balance. Classical RAS is viewed by cleavage of angiotensinogen (AGT) by renin to produce angiotensin I (Ang I), which is then converted to angiotensin II (Ang II) by angiotensin converting enzyme (ACE). The actions of the RAS are mediated mainly by the peptide Ang II through two types of receptors, AT1 and AT2, which are both seven-transmembrane G protein-coupled receptors, and can act either as a systemic hormone (endocrine) or as a locally generated cytokine (paracrine or autocrine). The AT1 receptor accounts for the majority of the known functions of Ang II in various tissues. Ang II also acts as a potent growth factor and cytokine for vascular smooth muscle cells, cardiac myocytes and cardiac fibroblasts (4, 12).
The presence of various components of the RAS in cardiac tissue has already been reported (18) . Although the origin of each component of this cardiac RAS is not completed know, mRNA expression for some of the RAS components provides support for the local generation of Ang II (9, 27).
There are many evidences on the role of the AT1 receptor in the development of cardiac hypertrophy in many pathologic or experimental states. It has already been demonstrated that AT1 mRNA expression increases in response to aortic coartation or acute myocardial infarction (6). Also, long-term treatment of stroke prone spontaneously hypertensive rats with AT1 blocker candesartan, significantly reduced left ventricular mass (34). In addition, benefits effects of AT1 receptor blocker on left ventricular hypertrophy also extend to patients with mild-to-moderate hypertension (10). In spite of that, there are only few studies about the role of the RAS in models of cardiac hypertrophy induced by exercise training. In this regard, we studied the rat cardiac hypertrophy in response to a resistance training program in the presence and absence of an AT1 blocker (losartan) and diet of 1% salt to inhibit release. This model of exercise training has been well established in our laboratory (2, 3).
METHODS

Animal
Thirty-six Wistar rats were assigned into six groups (n=6 each): control (CO), control treated with losartan (CO+LOS), control high salt diet (CO+SALT), trained (TR), trained treated with losartan (TR+LOS) and trained plus high salt diet (TR+SALT). Losartan (10mg.kg ) was administered in the drinking water at a known dose that blocks the AT1 receptor but does not decrease the blood pressure of normotensive rats (20). Salt (1%) was also administered in the drinking water at a known dose to inhibit the renin release but not to alter the BP (24). Salt loading was used only to uncouple local versus systemic activation of the RAS. Animals were housed in standard cages and food and water were provided ad libitum. The environmental temperature was kept at 23 ± 1 o C and a 12:12 h dark-light cycle was maintained throughout the experiment. Animals were weighed every week. All protocols and surgical procedures used were in accordance with the guidelines of the Brazilian College for Animal Experimentation and were approved by the Ethics Committee of the Institute of Biomedical Science of the University of Sao Paulo.
Exercise protocol
Animals were exercised following a model adapted from Tamaki et al.
(29). Rats fitted with a canvas jacket were able to regulate the twisting and flexion of their torsos and were suspended in a standard position on their hind
limbs. An electrical stimulation (20 V, 0.3 s duration, at 3 s intervals) was applied to the rat's tail through a surface electrode. As a result, the rats flexed their legs repeatedly, which lifted the weight-arm of the training apparatus. The TR groups were exercised by four sets of 12 repetitions with a 90 s rest period between each set, five times per week for 4 weeks. This exercise regimen was started after 2 weeks of adaptation. All training sessions were performed in a dark room.
After measurement of the maximum weight lifted (1RM) with the squat-training apparatus, the training load was set at 65-75% of 1RM. The 1RM was defined as the minimum load that the rats were unable to jump following electrical stimulation. On the day following BP and HR was recorded as described below, 
Arterial BP and HR
Twenty-four hours after the last training session and under pentobarbital anaesthesia (40 mg/kg IP), a cannula (PE-50) was inserted into the carotid artery, emerging through the back of the rat's neck. During the experimental session, this cannula was connected to a strain-gauge transducer (P23 Db;
Gould-Statham). Twenty-four hours after the surgery, arterial BP was recorded on a beat-to-beat basis (AT/CODAS) at a frequency of 100 Hz for 30 min in quiet, conscious, unrestrained rats. The data reported indicates the average of all values of systolic, diastolic and mean arterial pressure over the entire recording period of 30 min; HR was taken from BP pulse records.
Plasma Renin Activity Assay
The PRA was measured by angiotensin radioimmunoassay, using a commercial kit (REN-CT2, CIS Bio International, Gif-sur-Yvette, France). This assay permits direct measurement of PRA. Results were quantified in a Gama
Counter, and the enzyme activity was expressed as ng AngI/mL/h,
Angiotensin-converting enzyme activity assay
ACE activity in rat serum and tissue extracts were determined using Abz- 
Western blot analysis
The frozen ventricles were thawed and minced into small pieces and homogenized in cell lysis buffer containing 100 mM Tris, 50 mM NaCl, 10 mM EDTA, 1% TritonX-100 and a mixture of protease inhibitors. Insoluble heart tissues were removed by centrifugation at 3,000 × g, 4° C, 10 min. Samples were loaded and subjected to SDS-PAGE in 10% polyacrylamide gels. After electrophoresis, proteins were electro-transferred to nitrocellulose membrane 
Measurement of Ang II in heart tissue
Heart was homogenized in lysis buffer (sodium phosphate 0.1 M, sucrose 0.34 M, NaCl 0.3 M) containing a mixture of protease inhibitors and centrifuged at 10 000 x g , 4°C, 10 min. The supernatant was collected and it was passed through phenylsilica cartridges (Sep-Pak C18 columns, Waters), and the absorbed angiotensin was eluted with methanol. Eluate was dried in a vacuum centrifuge and the pellet was ressuspended in EIA buffer, mixed and centrifuged at 3000 g for 10 minutes at 4°C. Ang II levels were determined by ELISA, according to the manufacturer's instructions (SPI-BIO). The protein content was determined by the Bradford methods (5) by using bovine serum albumin as the standard (Bio-Rad Protein Assay). Table 1 shows the BW of the animals at the beginning and at the end of the study. There were no differences in the BW among all groups neither before nor after training protocol. Furthermore, all groups had the BW increased over the period except the TR+SALT group which increase was not significant (p>0.05). 
RESULTS
Body Weight (BW)
Maximal strength
Hemodynamics parameters
To confirm that the doses of Losartan and Salt used in this study would not influence the results, some hemodynamics parameters, such as BP and HR, were measured directly using an intra-arterial cannula. Table 1 shows the resting values of mean blood pressure (MBP) and heart rate (HR). Both BP and HR remained the same in all groups regardless of the treatment. Although resting BP was unchanged we have also measured the BP achieved during one session of exercise training. As already showed by many human studies, one RT session induces increase in BP. We have also found in this animal model systolic BP peak around of 180 mmHg, and these peaks were also similar apart from the administration of Losartan or Salt (data not shown).
Cardiac Hypertrophy
LV weight/BW ratio was approximately 8.5% and 10.6% greater in TR (2.15±0.05 mg/g) and TR+SALT (2.19±0.06 mg/g) group, respectively, compared to CO group (1.98±0.04 mg/g) ( Figure 1A , p<0.01). Among trained groups, LV hypertrophy was not observed in the animals that received the AT1 blocker Losartan (TR+LOS, 1.99±0.03 mg/g, Figure 1A ), which suggest a role for local RAS in exercise-induced cardiac hypertrophy. Also, there were no differences among the controls groups regardless of the treatment (CO vs. CO+LOS, 1.97±0.05 mg/g, vs. CO+SALT, 2.00±0.04 mg/g). To confirm these findings heart weight was also normalized to tibia length ( Figure 1B ). An increase of 9.6% in cardiac hypertrophy in the TR (22.8±0.9 mg/mm) in comparison to CO (20.8±1.8 mg/mm) was found.
To better understand whether hypertrophy is physiological or pathological, two markers of pathological hypertrophy, ANP expression and / MHC ratio, were analyzed and both were not altered after the resistance training ( Figure 3A) .
Renin-Angiotensin-System
Renin and ACE are the two main enzymes that regulate the formation of the peptide Ang II. Table 2 (ACE) and Figure 2 (Renin) show the activities of these enzymes. ACE activity was decreased by Losartan treatment, while no effect could be observed due to the RT. ACE activity was assessed in serum and locally in lung, kidney and heart but has been lower only by Losartan treatment in the serum. Furthermore, no influence could be observed in the Renin activity in response to RT. However, as expected, Losartan treatment increased renin activity possible due to the blockage of the negative feedback on renal juxtaglomerular cells production and increased release of renin (p<0.01); while Salt diet almost abolished its activity as has already been demonstrated by our group (24) (p<0.01). The lower ACE activity by Losartan treatment in the serum suggests a compensatory mechanism to increased renin activity in this group. Figure 3A shows the RT-PCR results of the gene expression of AGT, ACE and AT1a receptor in the heart between CO and TR groups. mRNA level of ACE was not altered as already suggested by ACE activity but AGT decreased 30% (P=0.066) and AT1a receptor increased 56% (p<0.05).
In regard of the protein expression, it can be observed that RT has no effect on the protein expression of both the AT2 receptor and Ang II ( Figure 3B and 3C). Furthermore, the Ang II concentration evaluated by IR confirms this result (CO, 23.27±2.4 pg/mg; TR, 22.01±0.8 pg/mg, Figure 3C ). However, there was an overexpression of the AT1 receptor protein (31%, Figure 3B ), which is in agreement with the increase in the AT1a mRNA. However, although the RT is also a cardiac stressor, these markers were not altered, which agree with our previous results of ventricular function (3).
DISCUSSION
The RT due to increased cardiac workload during the exercise sessions is Altogether, these findings and the ones of the present study suggest that it is very unlikely that Ang II plays a role in the cardiac hypertrophy after RT.
Our findings might be explained by recent studies suggesting that mechanical load can directly activate AT1 receptor even in the absence of Ang II.
A number of studies have addressed the role of AT1 receptor in cardiac hypertrophy using genetically modified mice models overexpressing AT1 receptor in the heart (14, 26, 32 showed no evidence of cardiac hypertrophy at 3 months of age. In the same study, using another transgenic mice that overexpressed a degradation-resistant form of Ang II, the hormone levels reached 100 times the normal levels and began to spill into the circulation. In spite of this, the animals again did not 
PERSPECTIVES AND SIGNIFICANCE
This study shows for the first time in the literature that local RAS contributes to the development of physiological cardiac hypertrophy in response to RT and that the AT1 receptor plays a key role on this adaptation. It allows future studies to investigate the mechanisms and the intracellular signaling by which different exercise training leads to different cardiac hypertrophy patterns, such as concentric and eccentric hypertrophy. Furthermore, this study suggests that the activation of RAS can also be observed even in physiological adaptations induced by RT in addition to the well know action of the RAS in the development of many cardiovascular diseases. 
